What You Should Know:
– Healthcare solutions company LetsGetChecked, today announced the acquisition of genomics pioneer Veritas Genetics and Veritas Intercontinental.
– Through these acquisitions, LetsGetChecked will leverage the power of whole-genome sequencing to launch a full lifecycle of personalized healthcare, delivering the most comprehensive health testing and care solution on the market.
LetsGetChecked, a leading healthcare solutions company acquires Veritas Genetics Inc. and Veritas Intercontinental, pioneers in genomics that share a scalable platform enabling the rapid interpretation of genetic information from a single gene to the whole genome. These acquisitions signify a crucial advancement in LetsGetChecked’s mission to empower individuals to take control of their health and enable both consumers and healthcare partners to be more proactive in healthcare management.
Veritas Genetics was co-founded in 2014 by Dr. George Church, a renowned pioneer in genomics from Harvard Medical School and MIT. Veritas Genetics was the first company to provide whole genome sequencing at an affordable price. The platform and interpretation methodology used by Veritas Genetics enables an efficient and effective interpretation of the genome, empowering customers with a comprehensive genetic profile and clinical report. Veritas Intercontinental was founded in 2018 as a spin-off from Veritas Genetics and has led the activity and development of Veritas outside of the United States, offering a wide range of genomic services.
Unlock the Future of Personalized At-Home Healthcare
In 2022, LetsGetChecked will offer a full range of genetic testing from whole-genome sequencing to more targeted panels and tests such as Pharmacogenomics (PGx), cancer screening, carrier screening, and maternal-fetal testing to its B2B and D2C audiences. LetsGetChecked will leverage these capabilities along with its existing diagnostic testing and virtual care model to enable consumers, employers, health plans, and other healthcare partners to use genetic information to guide personalized care, testing, and prevention.
“Through these acquisitions, LetsGetChecked will leverage the power of whole-genome sequencing to launch a full lifecycle of personalized healthcare, delivering the most comprehensive health testing and care solution on the market,” said Peter Foley, Founder and CEO of LetsGetChecked. “By integrating Veritas Genetics’ and Veritas Intercontinental’s capabilities with LetsGetChecked’s scalable diagnostic and virtual care infrastructure, we are able to turn comprehensive genetic insights into practical recommendations and lifestyle changes, guided by clinical experts.”
As the at-home health services market continues to experience exponential growth, expected to be worth over $2B by 2025, these acquisitions mark a crucial advancement in LetsGetChecked’s rapid rise in the telehealth market and comes on the heels of a monumental year when the brand reached +$1 billion valuation and unveiled CarePathway™, a longitudinal customer care journey that seeks to revolutionize specialty care by providing medication, regular testing, consultations, and personalized lifestyle support remotely.